The pharmaceutical industry is experiencing major upheavals, as PwC* noted in earlier Pharma 2020 papers. Many companies have responded by trying to discover, develop and market medicines more efficiently, but they’ve invested relatively little effort in re-configuring their manufacturing and distribution operations to date. Yet the supply chain is just as important; it’s the link between the laboratory and the marketplace.
Combine agile, economic manufacturing and distribution with the provision of satellite services to generate profits
We’ve identified four potential supplychain options from which pharma companies can choose. Those that focus on specialist medicines can either delegate all their manufacturing and distribution to trusted contractors or build service oriented supply chains to enhance their brands. Those that focus on mass-market medicines can either become low-cost providers or build supply chains that generate a profit by servicing both internal and external customers.
Cloud based solutions for Demand Forecasting to Intuitive algorithms to provide an Goal based solution across new manufacturing, distribution and service management techniques.
GET A DEMO
Your browser does not support iframes.